Treatments & Interventions
Calcium glycerophosphate
substance
Calcium glubionate
substance
Calcium phosphate
substance
Calcium citrate
substance
Calcitonin
substance
Calcium glucoheptonate
substance
Ibandronate
substance
Pamidronate
substance
Alendronate
substance
Raloxifene
substance
Teriparatide acetate
substance
Calcium pantothenate
substance
Salmon calcitonin
substance
Calcium acetate
substance
Risedronate sodium
substance
Calcium lactate
substance
Calcium gluconate
substance
Calcium carbonate
substance
Risedronate
substance
Alendronate sodium
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Quick Facts
- SNOMED CT
- 102447009
- UMLS CUI
- C0029458
- Fully Specified Name
- Postmenopausal osteoporosis (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 1
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.